Zdrowie i gospodarka · 14/04/2016

FDA Extends Comment Period for Oxitec Mosquito Study

The FDA is extending the comment period for its March 14, 2016, notice on the use of Oxitec OX513A mosquitoes, allowing more time for public input on the Draft Environmental Assessment and Preliminary Finding of No Significant Impact.